This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ruan, S. Articles by Shellito, J. E. Search for Related Content PubMed PubMed Citation Articles by Ruan, S. Articles by Shellito, J. E.

 Previous Article  |  Next Article 

Infection and Immunity, November 2002, p. 6107-6113, Vol. 70, No. 11
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.11.6107-6113.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Local Delivery of the Viral Interleukin-10 Gene Suppresses Tissue Inflammation in Murine Pneumocystis carinii Infection

Section of Pulmonary and Critical Care Medicine, Department of Medicine, Center for Lung Biology and Immunotherapy, Alcohol Research Center, and Gene Therapy Program, Louisiana State University Health Sciences Center, New Orleans, Louisiana,¹ Institute of Medical Immunology, Humboldt University, Berlin, Germany²

Received 27 June 2002/ Returned for modification 31 July 2002/ Accepted 14 August 2002

The relationship between tissue inflammation and clearance of the opportunistic pathogen Pneumocystis carinii is poorly understood. We asked whether the anti-inflammatory cytokine interleukin-10 (IL-10) is released during the host response to infection with P. carinii and whether local delivery of the IL-10 gene could suppress tissue inflammatory responses without compromising clearance of infection. Control and CD4-depleted mice were inoculated with P. carinii, and at serial intervals after inoculation, lung tissue was assayed for IL-10 by enzyme-linked immunosorbent assay. We found that IL-10 was released in lung tissue in control mice and was present in higher concentrations in CD4-depleted mice with progressive infection. Control and CD4-depleted mice were then pretreated with 10⁹ PFU of intratracheally administered adenoviral vector containing the viral IL-10 gene or the luciferase gene followed by inoculation with P. carinii. Pretreatment with viral IL-10 did not alter clearance of infection in control mice or severity of infection in CD4-depleted mice but did decrease tissue inflammation. We then asked whether gene transfer of viral IL-10 could decrease tissue inflammation during immune reconstitution. In these experiments, immunodeficient scid mice were inoculated with P. carinii and were heavily infected after 4 weeks. When these mice are immunologically reconstituted by intravenous administration of spleen cells from normal mice, a hyperinflammatory reaction developed in lung tissue, associated with high mortality. In comparison to control mice, mice treated with viral IL-10 prior to reconstitution showed significantly decreased lung wet weight, bronchoalveolar lavage fluid (BALF) lactate dehydrogenase, and BALF neutrophils. In contrast, infection intensity, as measured by PCR for P. carinii rRNA, was unchanged between the IL-10 and luciferase groups. Survival was also improved in the IL-10-treated mice. We conclude that release of IL-10 is part of the host response to infection with P. carinii and that gene therapy with viral IL-10 can lessen excessive tissue inflammation without altering pathogen clearance. In the setting of immune reconstitution and P. carinii pneumonia, pretreatment with the viral IL-10 gene decreases excessive tissue inflammation and improves survival. These results are relevant to acute respiratory failure after initiation of antibiotic treatment for human P. carinii pneumonia and to immune reconstitution syndromes in human immunodeficiency virus-positive patients started on highly active antiretroviral therapy.

Editor: T. R. Kozel

This article has been cited by other articles:

• Bhagwat, S. P., Gigliotti, F., Xu, H., Wright, T. W. (2006). Contribution of T cell subsets to the pathophysiology of Pneumocystis-related immunorestitution disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L1256-L1266 [Abstract] [Full Text]  
• Wang, J., Gigliotti, F., Maggirwar, S., Johnston, C., Finkelstein, J. N., Wright, T. W. (2005). Pneumocystis carinii Activates the NF-{kappa}B Signaling Pathway in Alveolar Epithelial Cells. Infect. Immun. 73: 2766-2777 [Abstract] [Full Text]  
• Srisodsai, A., Kurotani, R., Chiba, Y., Sheikh, F., Young, H. A., Donnelly, R. P., Kimura, S. (2004). Interleukin-10 Induces Uteroglobin-related Protein (UGRP) 1 Gene Expression in Lung Epithelial Cells through Homeodomain Transcription Factor T/EBP/NKX2.1. J. Biol. Chem. 279: 54358-54368 [Abstract] [Full Text]  
• Israel-Biet, D, Esvant, H, Laval, A M, Cadranel, J (2004). Impairment of {beta} chemokine and cytokine production in patients with HIV related Pneumocystis jerovici pneumonia. Thorax 59: 247-251 [Abstract] [Full Text]  
• Qureshi, M. H., Harmsen, A. G., Garvy, B. A. (2003). IL-10 Modulates Host Responses and Lung Damage Induced by Pneumocystis carinii Infection. J. Immunol. 170: 1002-1009 [Abstract] [Full Text]